NCT00081471View on ClinicalTrials.gov

A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Anemia
Interventions
DRUG

darbepoetin alfa

0.45 micrograms/kg sc (starting dose) weekly

DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

0.6 micrograms/kg sc (starting dose) once every 2 weeks

Trial Locations (98)

1871

Liverpool

2060

Antwerp

3000

Leuven

3052

Parkville

3186

Clayton

3818

Amersfoort

6847

Perth

11355

Flushing

11527

Athens

12100

Cuneo

13353

Berlin

16132

Genova

18103

Allentown

18536

Piraeus

23900

Lecco

24153

Salem

25030

Besançon

25198

Lleida

26506

Morgantown

26900

Lodi

27100

Pavia

28000

Chartres

28041

Madrid

28046

Madrid

28805

Madrid

29209

Columbia

31059

Toulouse

33744

Bay Pines

34471

Ocala

35128

Padua

37232

Nashville

40225

Düsseldorf

41100

Modena

44035

Nantes

44263

Dortmund

45220

Cincinnati

46017

Valencia

48236

Detroit

49933

Angers

50047

Prato

50142

Borås

53127

Bonn

54511

Vandœuvre-lès-Nancy

54629

Thessaloniki

59037

Lille

63741

Aschaffenburg

66046

Perpignan

68024

Colmar

68100

Alexandroupoli

69437

Lyon

71101

Shreveport

72076

Tübingen

75216

Dallas

75743

Paris

75908

Paris

77054

Houston

78705

Austin

80131

Napoli

80480

Salouël

89124

Reggio Calabria

90073

Los Angeles

90185

Umeå

91034

Cagliari

95655

Mather

94305-5114

Stanford

06902

Stamford

02135

Boston

02215

Boston

97201-2940

Portland

05401

Burlington

T2N 2T9

Calgary

T6G 2B7

Edmonton

V2C 2T1

Kamloops

V3L 3W7

New Westminster

V6Z 1Y6

Vancouver

R2H 2A6

Winnipeg

A1B 3V6

St. John's

N2G 1N9

Kitchener

N6A 5A5

London

M1H 3G4

Scarborough Village

M4N 3M5

Toronto

M5G 2C4

Toronto

H1T 2M4

Montreal

H3A 1A1

Montreal

S7K 1N4

Saskatoon

455 00

Ioannina

00184

Roma

6419 PC

Heerlen

00936-5067

San Juan

04009

Almería

08907

Barcelona

07014

Palma de Mallorca

B9 5SS

Birmingham

SM5 1AA

Carshalton

LE5 4PW

Leicester

SE1 9RT

London

SE22 8PT

London

SW17 0RE

London

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00081471 - A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis | Biotech Hunter | Biotech Hunter